Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tralokinumab plus topical corticosteroids for severe atopic dermatitis in adults inadequately controlled with or contraindicated to oral cyclosporine A
2018-000747-76Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Sep 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atopic dermatitis (AD) comparing Tralokinumab + topical corticosteroids with Placebo + topical corticosteroids (2 arms). Primary endpoint: EASI75. Started Sep 2018; status: completed.
02
Drugs
tralokinumab
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2018-000747-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000747-76.